InsiderClue
← All stocks

Arcturus Therapeutics Holdings Inc.

ARCT Net selling
CIK 0001768224 #3570 in the set updated 18 Sep 2026
Bought (120 mo)
$787.85K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$138.48M
$4.92M on a plan · $440.24K straight out of an exercise
Sold at will
$133.12M
21 of 39 sales
Net
−$137.69M
−$132.33M against sales at will

By person

11 insiders · 54 transactions
32.6×

Joseph E. Payne holds 32.6 times base salary in stock. $24.51M of shares against $750.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph E. Payne last reported holding, valued at $16.56, the price Common Stock was last bought or sold at on the open market here, on 15 Aug 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ultragenyx Pharmaceutical Inc. entity
Director
—
$124.28M (4)
−$124.28M
1,400,000
4.93%
$23.18M
−41.7%
Chivukula Pad
Chief Scientific Officer & COO
—
$12.16M (32)
−$12.16M
435,334
1.53%
$7.21M
−40.6%
SASSINE ANDY
Chief Financial Officer
$433.16K (5)
$1.60M (1)
−$1.17M
221,764
0.7802%
$3.67M
−7.6%
Kummerfeld Keith C
See Remarks
$20.35K (2)
$440.24K (2) scheduled
−$419.89K
950
0.0033%
$15.73K
—
Payne Joseph E
President and CEO
$170.34K (3)
—
+$170.34K
1,480,097
5.21%
$24.51M
+0.7%
FARRELL PETER C
Director
$99.67K (2)
—
+$99.67K
98,696
0.3472%
$1.63M
+14.2%
Marquet Magda
Director
$64.33K (2)
—
+$64.33K
50,793
0.1787%
$841.03K
+17.7%
BARLOW JAMES F
Director
—
—
—
13,131
0.0462%
$217.42K
+31.3%
Markels John
Director
—
—
—
3,131
0.0110%
$51.84K
—
Marantz Jing L.
Director
—
—
—
3,131
0.0110%
$51.84K
—
HOLMES EDWARD W
Director
—
—
—
3,131
0.0110%
$51.84K
—

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Chivukula Pad
15 Oct 2024
Chief Scientific Officer & COO
Sold on a plan
12,000
$20.76
$249.12K
Chivukula Pad
5 Jun 2024
Chief Scientific Officer & COO
Sold on a plan
114
$45.00
$5.13K
Chivukula Pad
3 Jun 2024
Chief Scientific Officer & COO
Sold on a plan
26,000
$40.01
$1.04M
Chivukula Pad
25 Mar 2024
Chief Scientific Officer & COO
Sold on a plan
17,435
$35.02
$610.57K
Chivukula Pad
19 Mar 2024
Chief Scientific Officer & COO
Sold on a plan
8,565
$35.01
$299.84K
Chivukula Pad
1 Nov 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$18.72
$93.60K
Chivukula Pad
2 Oct 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$25.61
$128.06K
Chivukula Pad
1 Sep 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$31.45
$157.26K
Chivukula Pad
1 Aug 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$34.91
$174.55K
Chivukula Pad
14 Jul 2023
Chief Scientific Officer & COO
Sold on a plan
25,000
$35.01
$875.25K
Chivukula Pad
3 Jul 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$28.75
$143.75K
Chivukula Pad
1 Jun 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$27.16
$135.80K
Chivukula Pad
11 May 2023
Chief Scientific Officer & COO
Sold on a plan
7,925
$30.24
$239.65K
Chivukula Pad
10 May 2023
Chief Scientific Officer & COO
Sold on a plan
17,075
$30.00
$512.25K
Chivukula Pad
1 May 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$25.93
$129.65K
Chivukula Pad
3 Apr 2023
Chief Scientific Officer & COO
Sold on a plan
5,000
$25.38
$126.90K
Show all 54 transactions →

What was left out

Form 4 filings counted 137
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 2
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 635,013
Sales filed before the plan box existed 20
History held since 21 Aug 2019